MMR (MLH1, PMS2, MSH2, or MSH6) deficiency, which is driven by inactivating methylation, was correlated with older age, advanced stage (II–IV), high grade of differentiation (G3), and larger tumor size [39]. This evidence concerns the gene MSH2 and neoplasm.